Ultragenyx Pharmaceutical Inc (MEX:RARE)
MXN 751.98 0 (0%) Market Cap: 65.87 Bil Enterprise Value: 59.05 Bil PE Ratio: 0 PB Ratio: 23.46 GF Score: 70/100

Ultragenyx Pharmaceutical Inc at TD Cowen Health Care Conference Transcript

Mar 04, 2024 / 02:10PM GMT
Release Date Price: MXN751.98
Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst

All right. Well, good morning, everybody, and thank you for joining us at the 44th Annual TD Cowen Healthcare Conference here in Boston. I'm Yaron Werber, on the biotech team, and it's a great pleasure to moderate this session with Ultragenyx, along with my colleague, Brendan Smith.

With us today, we have Eric Crombez, who is the Chief Medical Officer and EVP at Ultragenyx. Eric, good to see you.

Eric Crombez
Ultragenyx Pharmaceutical Inc. - Chief Medical Officer & Executive VP

Good to see you.

Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst

Thanks for joining us.

Questions & Answers

Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst

So lots going on from Ultragenyx this year. This is really going to be a year of pipeline, both Phase III pipeline and Phase sort of II pipeline

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot